Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease

• Published in: Neurobiology of aging 2021-04, Vol.100, p.119.e7-119.e13
• Main Authors: Saini, Prabhjyot, Rudakou, Uladzislau, Yu, Eric, Ruskey, Jennifer A., Asayesh, Farnaz, Laurent, Sandra B., Spiegelman, Dan, Fahn, Stanley, Waters, Cheryl, Monchi, Oury, Dauvilliers, Yves, Dupré, Nicolas, Greenbaum, Lior, Hassin-Baer, Sharon, Espay, Alberto J., Rouleau, Guy A., Alcalay, Roy N., Fon, Edward A., Postuma, Ronald B., Gan-Or, Ziv
• Format: Article
• Language: English
• Subjects: Ashkenazi-Jewish; Carrier Proteins; Cohort Studies; DNAJC13; EIF4G1; Eukaryotic Initiation Factor-4G; Female; French-Canadian; Genetic Association Studies - methods; Geriatry and gerontology; GIGYF2; High-Temperature Requirement A Serine Peptidase 2; HTRA2; Human health and pathology; Humans; Life Sciences; Male; Molecular Chaperones; Negative Results; Neurons and Cognition; Parkinson Disease - genetics; Parkinson's disease; SKAT-O; Ubiquitin Thiolesterase; UCHL1; Whites - genetics
• ISSN: 0197-4580; 1558-1497
• DOI: 10.1016/j.neurobiolaging.2020.10.019

Rare mutations in genes originally discovered in multigenerational families have been associated with increased risk of Parkinson's disease (PD). The involvement of rare variants in DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 loci has been poorly studied or has produced conflicting results across cohorts. However, they are still being often referred to as “PD genes” and used in different models. To further elucidate the role of these 5 genes in PD, we fully sequenced them using molecular inversion probes in 2408 patients with PD and 3444 controls from 3 different cohorts. A total of 788 rare variants were identified across the 5 genes and 3 cohorts. Burden analyses and optimized sequence Kernel association tests revealed no significant association between any of the genes and PD after correction for multiple comparisons. Our results do not support an association of the 5 tested genes with PD. Combined with previous studies, it is unlikely that any of these genes plays an important role in PD. Their designation as “PARK” genes should be reconsidered.